MDT

86.86

-0.29%↓

A

115.79

+0.61%↑

VEEV

155.13

+2.42%↑

HQY

78.46

+0.44%↑

TLRY

6.41

-2.58%↓

MDT

86.86

-0.29%↓

A

115.79

+0.61%↑

VEEV

155.13

+2.42%↑

HQY

78.46

+0.44%↑

TLRY

6.41

-2.58%↓

MDT

86.86

-0.29%↓

A

115.79

+0.61%↑

VEEV

155.13

+2.42%↑

HQY

78.46

+0.44%↑

TLRY

6.41

-2.58%↓

MDT

86.86

-0.29%↓

A

115.79

+0.61%↑

VEEV

155.13

+2.42%↑

HQY

78.46

+0.44%↑

TLRY

6.41

-2.58%↓

MDT

86.86

-0.29%↓

A

115.79

+0.61%↑

VEEV

155.13

+2.42%↑

HQY

78.46

+0.44%↑

TLRY

6.41

-2.58%↓

Search

Atossa Therapeutics Inc

Open

4.92 0.2

Overview

Share price change

24h

Current

Min

4.91

Max

4.97

Key metrics

By Trading Economics

Income

-2.2M

-11M

Employees

16

EBITDA

-2.7M

-11M

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+271.05% upside

Market Stats

By TradingEconomics

Market Cap

-4M

44M

Previous open

4.72

Previous close

4.92

Technical Score

By Trading Central

Confidence

Bullish Evidence

Atossa Therapeutics Inc Chart

Past performance is not a reliable indicator of future results.

Related News

16 Jan 2026, 23:29 UTC

Hot Stocks

Stocks to Watch: Atossa Therapeutics, Union Pacific

Peer Comparison

Price change

Atossa Therapeutics Inc Forecast

Price Target

By TipRanks

271.05% upside

12 Months Forecast

Average 18.33 USD  271.05%

High 25 USD

Low 10 USD

Based on 3 Wall Street analysts offering 12 month price targets forAtossa Therapeutics Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

3 ratings

3

Buy

0

Hold

0

Sell

Technical Score

By Trading Central

0.7955 / 0.898Support & Resistance

Short Term

Bullish Evidence

Intermediate Term

Strong Bullish Evidence

Long Term

Weak Bearish Evidence

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

help-icon Live chat